Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation

Evogene (Nasdaq: EVGN) announced that Chairman Nir Nimrodi will participate in the company’s upcoming quarterly results Zoom conference call on Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time).

Rhea-AI Summary

Evogene (Nasdaq: EVGN) announced that Chairman Nir Nimrodi will participate in the company’s upcoming quarterly results Zoom conference call on Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time). The call will be accessible via advance online registration and a replay will be posted on Evogene’s website.

Argus Aug 14 session 10 alerts

-7.71% close to close 1.6x rel. volume Open Argus

Details

News Market Reaction – EVGN

-4.7% Trough in 5 hr 29 min

$9.22M Market Cap

On Aug 14, the day this news came out, EVGN closed 7.71% below the previous close. Argus tracked a trough of -4.7% from its starting point during tracking. Our momentum scanner recorded 10 alerts for this stock that day. Relative volume reached 1.6x the daily average during tracking.

Data tracked by StockTitan Argus for the Aug 14 session.

Market Context

On Aug 14, the day this news came out, the stock closed 7.7% below the previous close. A prior AI mi...

Analysis

On Aug 14, the day this news came out, the stock closed 7.7% below the previous close. A prior AI milestone was followed by a -10.55% 24-hour move. A strong negative response here would contrast with recent Net Buying by a director, while the active F-3 resale registration remains documented secondary-sale context.

Key Figures

Conference Call Date: August 18, 2026 Eastern Time: 9:00 AM ET Israel Time: 4:00 PM Israel time

Conference Call Date

August 18, 2026

Upcoming quarterly results call

Eastern Time

9:00 AM ET

Conference call start time

Israel Time

4:00 PM Israel time

Conference call start time

Historical Context

5 past events · Latest: Jul 30

5 events

1. Jul 30

   results scheduling

   24h Move

   +1.6%

   Second-quarter results release and conference call scheduled for August 18

2. Jul 22

   strategic collaboration

   24h Move

   +2.3%

   ELEO collaboration targeted oral PCSK9 pathway inhibitors for cardiovascular diseases

3. Jul 15

   AI model launch

   24h Move

   +19.9%

   AgPlenus launched an antifungal potency prediction model for fungicide discovery

4. Jul 08

   AI drug initiative

   24h Move

   -2.5%

   Evogene and Tel Aviv University announced an AI-driven drug discovery initiative

5. Jun 24

   AI platform milestone

   24h Move

   -10.6%

   Google Cloud collaboration milestone expanded autonomous small-molecule discovery capabilities

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

computational chemistry, generative design, dissident shareholders

3 terms

computational chemistry technical

"a pioneering company in computational chemistry, specializing in the generative design"

Computational chemistry uses computer models and simulations to predict how molecules behave, how they interact, and what chemical reactions they may undergo. For investors, it matters because these virtual experiments can speed up drug discovery, materials design, and cost estimates—like using a wind tunnel for cars—helping companies reduce development time, lower research costs, and de‑risk projects before expensive lab work or clinical trials.

generative design technical

"specializing in the generative design of small molecules for the pharmaceutical"

Generative design is a computer-driven process that takes goals, limits and available materials and produces many possible product shapes and layouts, similar to telling a smart assistant the ingredients you have and getting dozens of recipe options. For investors, it matters because it can cut engineering time, lower manufacturing costs, create lighter or stronger products, and enable faster innovation — all of which can improve margins, shorten time to market and change competitive dynamics.

dissident shareholders regulatory

"the current situation involving certain dissident shareholders"

Shareholders who publicly challenge a company’s management or board and push for specific changes in strategy, governance, leadership, or capital allocation. They act like a group of tenants organizing to force repairs or new rules: using formal tools such as shareholder proposals, proxy fights, or voting campaigns to try to replace directors, change policies, or influence major decisions. Their actions matter to investors because they can prompt boardroom change, affect short‑term share price volatility, and alter a company’s long‑term direction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET

REHOVOT, Israel, Aug. 14, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that its Chairman, Nir Nimrodi, will join the Company's upcoming quarterly results conference call on August 18, 2026. 

Mr. Nimrodi will address the current situation involving certain dissident shareholders. Mr. Nimrodi will discuss the Company's perspective on these developments and the potential implications of those dissidents' attempted actions for Evogene and its shareholders. 

The conference call is scheduled for Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time).

To attend the conference, please register in advance: 
https://www.veidan-conferencing.com/evogene

The entire conference will be available online on the Company's website a few days after the call.

About Evogene:

Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for drug development and ag chemical products. At the core of its technology is ChemPass AI™, a proprietary generative AI designed to explore vast chemical space and generate novel, highly potent small molecules optimized across multiple critical parameters. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products for the pharmaceutical and agricultural industries, driven by the integration of scientific innovation with real-world industry needs.

For more information, please visit www.evogene.com.

Contact 
ir@evogene.com
Tel: +972-8-9311901

View original content to download multimedia:https://www.prnewswire.com/news-releases/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation-302851346.html

SOURCE Evogene

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Evogene (EVGN) holding its next quarterly results conference call in August 2026?

Evogene will hold its next quarterly results conference call on Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time). According to Evogene, the event will be conducted via Zoom and requires advance registration.

Will Evogene Chairman Nir Nimrodi join the EVGN quarterly call on August 18, 2026?

Yes, Chairman Nir Nimrodi will join Evogene’s quarterly results conference call on August 18, 2026. According to Evogene, he will participate alongside management to discuss company matters during the scheduled Zoom event.

How can investors register for Evogene’s (EVGN) quarterly Zoom conference call on August 18, 2026?

Investors can register in advance via the dedicated link https://www.veidan-conferencing.com/evogene. According to Evogene, prior registration is required to attend the Zoom call scheduled for August 18, 2026, at 9:00 AM Eastern Time.

Will a replay of Evogene’s August 18, 2026 quarterly results call be available online?

Yes, a replay of the entire conference will be available on Evogene’s website a few days after the call. According to Evogene, investors who cannot attend live will be able to access the recorded event online.

What time is Evogene’s August 18, 2026 earnings call in Israel time?

Evogene’s quarterly results conference call on August 18, 2026, starts at 4:00 PM Israel time. According to Evogene, this corresponds to 9:00 AM Eastern Time, and the meeting will be held via Zoom after advance registration.